Wendel Bruce

ImmunityBio, Inc. · Director

Wendel Bruce is listed in filings as Director at ImmunityBio, Inc.. This profile follows SEC Form 4 activity through Dec 16, 2025, including 1 public disclosure. Recent filings connect the profile to ImmunityBio, Inc. (IBRX). The current snapshot covers public activity from Dec 16, 2025. Reported amounts are shown as $344.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.